Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
2022 · New England Journal of Medicine · 451 citations
https://doi.org/10.1056/nejmoa2211023
J
J. Antonio G. López
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
4.5K
Citations
28
h-index
59
i10-index
J. Antonio G. López is an academic researcher from University of Central Florida. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Atherosclerosis and Cardiovascular Diseases & Diabetes, Cardiovascular Risks, and Lipoproteins. The author has an h-index of 28, co-authored 110 publications.
ORCID: 0000-0001-8604-5549Papers by this author
worksNonbacterial thrombotic endocarditis: A review
1987 · American Heart Journal · 400 citations
https://doi.org/10.1016/0002-8703(87)90719-8
The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy
2019 · Journal of clinical lipidology · 53 citations
https://doi.org/10.1016/j.jacl.2019.04.011
The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering
2024 · Journal of the American College of Cardiology · 48 citations
https://doi.org/10.1016/j.jacc.2024.05.058
Is vitality assessment important in neonatal animals?
2018 · CABI Reviews · 28 citations
https://doi.org/10.1079/pavsnnr201813036
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics
2019 · American Heart Journal · 10 citations
https://doi.org/10.1016/j.ahj.2019.11.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat